Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in J Biol Chem Retrieve available abstracts of 35 articles: HTML format

Single Articles

September 2024
1. BERNA-ERRO A, Lopez JJ, Jardin I, Sanchez-Collado J, et al
   Differential functional role of Orai1 variants in constitutive Ca(2+) entry and calcification in luminal breast cancer cells.
   J Biol Chem. 2024 Sep 18:107786. doi: 10.1016/j.jbc.2024.107786.
   PubMed     Abstract available
   
   
   
2. ZHANG J, Chen Y, Gong X, Yang Y, et al
   GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in breast cancer patients.
   J Biol Chem. 2024 Sep 12:107780. doi: 10.1016/j.jbc.2024.107780.
   PubMed     Abstract available
   
   
   
3. CHEN X, Li D, Su Q, Ling X, et al
   SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer.
   J Biol Chem. 2024 Sep 11:107764. doi: 10.1016/j.jbc.2024.107764.
   PubMed     Abstract available
   
   
   
4. QIAN T, Bai F, Zhang S, Xu Y, et al
   USP11 deubiquitinates E-cadherin and maintains luminal fate of mammary tumor cells to suppress breast cancer.
   J Biol Chem. 2024 Sep 11:107768. doi: 10.1016/j.jbc.2024.107768.
   PubMed     Abstract available
   
   
   August 2024
5. TANG K, Yin T, Deng B, Wang M, et al
   USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.
   J Biol Chem. 2024 Aug 9:107672. doi: 10.1016/j.jbc.2024.107672.
   PubMed     Abstract available
   
   
   July 2024
6. PERRON T, Boissan M, Bieche I, Courtois L, et al
   CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer.
   J Biol Chem. 2024 Jul 24:107601. doi: 10.1016/j.jbc.2024.107601.
   PubMed     Abstract available
   
   
   June 2024
7. GUO Q, Zhao J, Li Y, Zhang C, et al
   CK2-HTATSF1-TOPBP1 signaling axis modulates tumor chemotherapy response.
   J Biol Chem. 2024;300:107377.
   PubMed     Abstract available
   
   
   May 2024
8. PANDEY A, Kakani P, Shukla S
   CTCF and BORIS-mediated Autophagy regulation via Alternative splicing of BNIP3L in Breast Cancer.
   J Biol Chem. 2024 May 27:107416. doi: 10.1016/j.jbc.2024.107416.
   PubMed     Abstract available
   
   
   
9. DUAN L, Tadi MJ, O'Hara KM, Maki CG, et al
   Novel markers of MCL1 inhibitor sensitivity in triple negative breast cancer cells.
   J Biol Chem. 2024 May 16:107375. doi: 10.1016/j.jbc.2024.107375.
   PubMed     Abstract available
   
   
   April 2024
10. YANG P, Li Y, Hou J, Wu D, et al
    Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.
    J Biol Chem. 2024 Apr 22:107309. doi: 10.1016/j.jbc.2024.107309.
    PubMed     Abstract available
    
    
    
11. GOEL HL, Karner ER, Kumar A, Mukhopadhyay D, et al
    YAP/TAZ-mediated regulation of laminin 332 is enabled by beta4 integrin repression of ZEB1 to promote ferroptosis resistance.
    J Biol Chem. 2024;300:107202.
    PubMed     Abstract available
    
    
    October 2023
12. QIU T, Hou L, Zhao L, Wang X, et al
    SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1.
    J Biol Chem. 2023 Oct 12:105351. doi: 10.1016/j.jbc.2023.105351.
    PubMed     Abstract available
    
    
    July 2023
13. HOGSTROM JM, Cruz KA, Selfors LM, Ward MN, et al
    Simultaneous isolation of hormone receptor positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
    J Biol Chem. 2023 Jul 7:105021. doi: 10.1016/j.jbc.2023.105021.
    PubMed     Abstract available
    
    
    May 2023
14. BONHAM CA, Mandati V, Singh RK, Pappin DJ, et al
    Coupling substrate-trapping with proximity-labeling to identify protein tyrosine phosphatase PTP1B signaling networks.
    J Biol Chem. 2023;299:104582.
    PubMed     Abstract available
    
    
    January 2023
15. WANG W, Zhang Z, Zhao M, Wang Y, et al
    Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.
    J Biol Chem. 2023;299:102812.
    PubMed     Abstract available
    
    
    
16. VALLET A, El Ezzy M, Diennet M, Haidar S, et al
    The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.
    J Biol Chem. 2023;299:102757.
    PubMed     Abstract available
    
    
    December 2022
17. DONAHUE K, Xie H, Li M, Gao A, et al
    Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.
    J Biol Chem. 2022;298:102700.
    PubMed     Abstract available
    
    
    
18. SLADE L, Biswas D, Kienesberger PC, Pulinilkunnil T, et al
    Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells.
    J Biol Chem. 2022;298:102692.
    PubMed     Abstract available
    
    
    November 2022
19. ALWANIAN WM, Vlajic K, Bie W, Kajdacsy-Balla A, et al
    Protein tyrosine kinase 6 regulates activation of SRC kinase.
    J Biol Chem. 2022;298:102584.
    PubMed     Abstract available
    
    
    October 2022
20. WANG J, Liu X, Li P, Wang J, et al
    Long non-coding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-kappaB signaling pathway.
    J Biol Chem. 2022 Oct 20:102630. doi: 10.1016/j.jbc.2022.102630.
    PubMed     Abstract available
    
    
    
21. GUO Q, Qiu Y, Liu Y, He Y, et al
    Cell adhesion molecule CD44v10 promotes stem-like properties in triple-negative breast cancer cells via glucose transporter GLUT1-mediated glycolysis.
    J Biol Chem. 2022 Oct 12:102588. doi: 10.1016/j.jbc.2022.102588.
    PubMed     Abstract available
    
    
    August 2022
22. SU K, Collins MP, McGuire CM, Alshagawi MA, et al
    Isoform a4 of the vacuolar ATPase a subunit promotes 4T1-12B breast cancer cell-dependent tumor growth and metastasis in vivo.
    J Biol Chem. 2022 Aug 18:102395. doi: 10.1016/j.jbc.2022.102395.
    PubMed     Abstract available
    
    
    
23. HAWORTH AS, Hodges SL, Capatina AL, Isom LL, et al
    Subcellular dynamics and functional activity of the cleaved intracellular domain of the Na(+) channel beta1 subunit.
    J Biol Chem. 2022;298:102174.
    PubMed     Abstract available
    
    
    July 2022
24. AL KHAMICI H, Sanchez VC, Yan H, Cataisson C, et al
    The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells.
    J Biol Chem. 2022 Jul 18:102275. doi: 10.1016/j.jbc.2022.102275.
    PubMed     Abstract available
    
    
    June 2022
25. JI R, Shi Q, Cao Y, Zhang J, et al
    Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation.
    J Biol Chem. 2022;298:102033.
    PubMed     Abstract available
    
    
    May 2022
26. ZHANG X, Zhang R, Hou C, He R, et al
    FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
    J Biol Chem. 2022 May 31:102082. doi: 10.1016/j.jbc.2022.102082.
    PubMed     Abstract available
    
    
    
27. AKIMOTO M, Susa T, Okudaira N, Hisaki H, et al
    A Novel LncRNA PTH-AS Upregulates Interferon-Related DNA damage resistance Signature genes and Promotes Metastasis in Human Breast Cancer Xenografts.
    J Biol Chem. 2022 May 23:102065. doi: 10.1016/j.jbc.2022.102065.
    PubMed     Abstract available
    
    
    April 2022
28. LI Q, Zhong X, Yao W, Yu J, et al
    Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity.
    J Biol Chem. 2022;298:101753.
    PubMed     Abstract available
    
    
    March 2022
29. CHA JH, Chan LC, Wang YN, Chu YY, et al
    Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
    J Biol Chem. 2022 Mar 9:101817. doi: 10.1016/j.jbc.2022.101817.
    PubMed     Abstract available
    
    
    
30. MEDEIROS PJ, Pascetta SA, Kirsh SM, Al-Khazraji BK, et al
    Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
    J Biol Chem. 2022;298:101645.
    PubMed     Abstract available
    
    
    February 2022
31. EAST MP, Johnson GL
    Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition.
    J Biol Chem. 2022;298:101525.
    PubMed     Abstract available
    
    
    January 2022
32. ZHANG S, Wang R, Wang X, Guo X, et al
    HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer.
    J Biol Chem. 2022 Jan 27:101644. doi: 10.1016/j.jbc.2022.101644.
    PubMed     Abstract available
    
    
    
33. KAWASE N, Sugihara A, Kajiwara K, Hiroshima M, et al
    SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
    J Biol Chem. 2022 Jan 24:101630. doi: 10.1016/j.jbc.2022.101630.
    PubMed     Abstract available
    
    
    November 2021
34. WANG J, Dong Y, Ma H, Wu L, et al
    The Deubiquitinase USP28 Stabilizes Expression of RecQ Family Helicases and Maintains the Viability of Triple Negative Breast Cancer Cells.
    J Biol Chem. 2021 Nov 22:101443. doi: 10.1016/j.jbc.2021.101443.
    PubMed     Abstract available
    
    
    September 2021
35. MANNE RK, Agrawal Y, Malonia SK, Banday S, et al
    FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX.
    J Biol Chem. 2021 Sep 26:101253. doi: 10.1016/j.jbc.2021.101253.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.